瑞典学龄儿童特应性皮炎患病率下降:三项重复人群调查
研究通过1996、2006和2017年瑞典Norrbotten地区三组8岁左右学龄儿童(n=3430、2585、2785)的重复横断面调查,使用相同ISAAC问卷评估特应性皮炎(AD)患病率趋势。结果显示AD患病率从1996年22.8%和2006年21.3%降至2017年16.3%(P<0.001),医生诊断AD(D-AD)从9.3%和9.4%降至5.7%(P<0.001);而AD患儿中哮喘等特应性共病增加。
要点
- 瑞典学龄儿童AD患病率从1996年22.8%和2006年21.3%降至2017年16.3%(P<0.001)。
- 医生诊断AD患病率从9.3%和9.4%降至5.7%(P<0.001),下降模式一致。
- AD患儿中哮喘从12.2%(1996)增至23.0%(2017),过敏性鼻炎和致敏先升后趋平。
核心结论
- 瑞典学龄儿童AD患病率在研究期间下降,但AD患儿的特应性共病增加,尤其是哮喘增加值得关注。
- 尽管AD患病率下降,AD仍较常见。
研究设计与样本
- 三项重复的基于人群的横断面调查,比较1996年(n=3430)、2006年(n=2585)和2017年(n=2785)瑞典Norrbotten地区学龄儿童(中位年龄8岁)的数据。
- 三个队列使用相同的包含ISAAC方案问题的问卷。
主要发现
- AD患病率从1996年22.8%和2006年21.3%降至2017年16.3%(P<0.001)。
- 医生诊断AD(D-AD)患病率从1996年9.3%和2006年9.4%降至2017年5.7%(P<0.001)。
- 2017年AD在女孩中比男孩更常见(18.9% vs 13.8%,P<0.001)。
- 2017年山区内陆儿童AD患病率高于沿海城市儿童(22.0% vs 15.1%,P<0.001)。
- AD患儿中哮喘从1996年12.2%增至2006年15.8%和2017年23.0%(P<0.001);过敏性鼻炎和致敏从1996年15.0%和27.5%升至2006年24.7%和49.5%,至2017年趋于平稳(21.0%和46.7%)。
关键数值与推荐
- AD患病率:1996年22.8%,2006年21.3%,2017年16.3%(P<0.001)。
- D-AD患病率:1996年9.3%,2006年9.4%,2017年5.7%(P<0.001)。
- 2017年AD患病率女孩18.9% vs 男孩13.8%(P<0.001);山区内陆22.0% vs 沿海城市15.1%(P<0.001)。
- D-AD在性别间及内陆与沿海间无显著差异。
- AD患儿中哮喘:1996年12.2%,2006年15.8%,2017年23.0%(P<0.001)。
临床怎么用
- 在瑞典学龄儿童中,AD患病率呈下降趋势,但AD患儿中特应性共病(尤其是哮喘)增加,临床评估AD患儿时应关注共病情况。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The prevalence of atopic dermatitis (AD) has increased over several decades and now affects about one-fifth of all children in high-income countries (HICs). While the increase continues in lower-income countries, the prevalence of AD might have reached a plateau in HICs. OBJECTIVES: To investigate trends in the prevalence of AD and atopic comorbidity in schoolchildren in Sweden. METHODS: The study population consisted of three cohorts of children (median age 8 years) in Norrbotten, Sweden, for 1996 (n = 3430), 2006 (n = 2585) and 2017 (n = 2785). An identical questionnaire that included questions from the International Study of Asthma and Allergies in Childhood (ISAAC) protocol was used in all three cohorts. Trends in AD prevalence were estimated, as well as trends in atopic comorbidity. AD prevalence was estimated both according to the ISAAC definition of AD and by adding the reported diagnosis by a physician (D-AD). RESULTS: The prevalence of AD decreased in the last decade, from 22.8% (1996) and 21.3% (2006) to 16.3% (2017; P < 0.001). The prevalence of D-AD was lower, but the same pattern of decrease was seen, from 9.3% (1996) and 9.4% (2006) to 5.7% (2017; P < 0.001). In all three cohorts, AD was more common among girls than boys (18.9% vs. 13.8% in 2017; P < 0.001). Children from the mountain inlands had a higher prevalence of AD than children from coastal cities (22.0% vs. 15.1% in 2017; P < 0.001). In comparing D-AD, there were no significant differences between the sexes or between inland or coastal living. Concomitant asthma increased over the years from 12.2% (1996) to 15.8% (2006) to 23.0% (2017; P < 0.001). Concomitant allergic rhinitis and allergic sensitization increased from 1996 (15.0% and 27.5%) to 2006 (24.7% and 49.5%) but then levelled off until 2017 (21.0% and 46.7%). CONCLUSIONS: The prevalence of AD among schoolchildren in Sweden decreased over the study period, whereas atopic comorbidity among children with AD increased. Although a decrease was seen, AD is still common and the increase in atopic comorbidity among children with AD, especially the increase in asthma, is concerning.
引用
- Af Klinteberg M, Winberg A, Andersson M, et al. Decreasing prevalence of atopic dermatitis in Swedish schoolchildren: three repeated population-based surveys. Br J Dermatol. 2024. PMID: 37776301. doi:10.1093/bjd/ljad370
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。